Google · Funding and deals · Research
DeepMind-born drug discovery company Isomorphic Labs in funding talks at a $40-50 billion valuation
Isomorphic Labs, the AI drug discovery company spun out of Google DeepMind, is in early talks to raise new money at a valuation of at least $40 billion, Bloomberg reported on October 8, citing people familiar with the matter. The round could value the company at up to $50 billion, though nothing is final and terms may change. Founded by Demis Hassabis inside Alphabet in 2021 and built on DeepMind’s AlphaFold work, the London-based firm raised a $2.1 billion Series B led by Thrive Capital in May 2026. It has partnerships with Eli Lilly, Novartis and Johnson & Johnson. Isomorphic has not publicly confirmed the report.
Sources
- Bloomberg, “Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value”, (bloomberg.com)
- Isomorphic Labs, “Isomorphic Labs announces Series B investment round”, (isomorphiclabs.com)
- Isomorphic Labs, “Isomorphic Labs Enters into a Research Collaboration with Johnson & Johnson”, (isomorphiclabs.com)
About this story
This story was posted on Instagram by @jarrus.tech on Oct. 8, 2026.
Spotted an error in this story? [email protected] · Instagram
Short link: thejarrus.com/en/isomorphic-funding
This story in Turkish: DeepMind’dan doğan ilaç keşif şirketi Isomorphic Labs, 40-50 milyar dolar değerlemeyle yatırım görüşüyor
On the same topic
Robot tests: even the best model completed only 19% of 84 robot tasks, and 63 tasks were solved by no model
In RobotWorld, a benchmark released October 7, the top model, GPT-6 Astra, completed only 16 of 84 simulated robot tasks; no model solved 63 of the tasks.
OpenAI’s image model posts a near-perfect score on text-dense images
On UltraText Bench, a dense-text test led by Westlake University, OpenAI’s GPT Image 2 ranked first of 24 configurations with 99.35 out of 100.
Anthropic is running a lab that does biology experiments in the Bay Area
Anthropic runs a Bay Area biology lab where it aims to have Claude direct automated lab equipment under human supervision, with a focus on fundamental biology.